CH479700A - Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit - Google Patents

Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit

Info

Publication number
CH479700A
CH479700A CH543765A CH543765A CH479700A CH 479700 A CH479700 A CH 479700A CH 543765 A CH543765 A CH 543765A CH 543765 A CH543765 A CH 543765A CH 479700 A CH479700 A CH 479700A
Authority
CH
Switzerland
Prior art keywords
virus
obtaining
production
influenza vaccines
allantoic fluid
Prior art date
Application number
CH543765A
Other languages
English (en)
Inventor
Herzberg Kurt
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of CH479700A publication Critical patent/CH479700A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH543765A 1964-04-22 1965-04-20 Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit CH479700A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76450A DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen

Publications (1)

Publication Number Publication Date
CH479700A true CH479700A (de) 1969-10-15

Family

ID=6979080

Family Applications (1)

Application Number Title Priority Date Filing Date
CH543765A CH479700A (de) 1964-04-22 1965-04-20 Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit

Country Status (13)

Country Link
US (1) US3422187A (de)
AT (1) AT259760B (de)
BE (1) BE662899A (de)
BR (1) BR6569124D0 (de)
CH (1) CH479700A (de)
DE (1) DE1246167B (de)
DK (1) DK110208C (de)
FI (1) FI41428C (de)
FR (1) FR1590063A (de)
GB (1) GB1099555A (de)
LU (1) LU48383A1 (de)
NL (1) NL6505122A (de)
SE (1) SE308575B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085203A (en) * 1972-04-26 1978-04-18 Burroughs Wellcome Co. Process for preparing vaccine
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US9476123B2 (en) 2005-05-31 2016-10-25 Aspen Aerogels, Inc. Solvent management methods for gel production
US20060270248A1 (en) * 2005-05-31 2006-11-30 Gould George L Solvent Management Methods for Gel Production

Also Published As

Publication number Publication date
BE662899A (de)
BR6569124D0 (pt) 1973-09-20
NL6505122A (de) 1965-10-25
GB1099555A (en) 1968-01-17
FR1590063A (de) 1970-04-13
FI41428C (fi) 1969-11-10
LU48383A1 (de) 1966-10-13
DK110208C (da) 1970-12-21
DE1246167B (de) 1967-08-03
US3422187A (en) 1969-01-14
FI41428B (de) 1969-07-31
AT259760B (de) 1968-02-12
SE308575B (de) 1969-02-17

Similar Documents

Publication Publication Date Title
CH457842A (de) Verfahren zur Herstellung einer Polymerdispersion
CH467850A (de) Verfahren zur Herstellung einer fluidisierbaren Polyepoxydzubereitung
CH472368A (de) Verfahren zur Herstellung eines sekundären Aralkylamins
CH503786A (de) Verfahren zur Herstellung einer Emaille-Zubereitung
AT282824B (de) Verfahren zur Herstellung einer neuen Adjuvansvaccine
AT265526B (de) Verfahren zur Herstellung eines Desinfektionsmittels
CH479700A (de) Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit
AT284605B (de) Verfahren zur Herstellung einer Gelierhilfe
CH451915A (de) Verfahren zur Herstellung eines neuen Amins
CH439274A (de) Verfahren zur Herstellung eines Cyclopentenonderivates
CH467289A (de) Verfahren zur Herstellung des Phosphats einer Diphenylamin-4-diazoniumbase
AT261122B (de) Verfahren zur Herstellung eines Desinfektionsmittels
CH453176A (de) Verfahren zur Herstellung eines Leuchtsatzes
AT273636B (de) Verfahren zur Herstellung eines Präparates mit Fleischgeschmack
AT265517B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
CH475940A (de) Verfahren zur Herstellung von Dibenzocyclohepten-derivaten
CH447204A (de) Verfahren zur Herstellung einer Trioxanlösung
AT270069B (de) Verfahren zur Herstellung einer injizierbaren Influenzavaccinezubereitung
AT285044B (de) Verfahren zur Herstellung einer somatischen Antigenvaccine
CH466894A (de) Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis
AT286497B (de) Verfahren zur Herstellung einer Vaccine
AT257043B (de) Verfahren zur Herstellung einer Vakzineflüssigkeit von Brucella Abortus-Bakterien
CH446313A (de) Verfahren zur Herstellung von Dibenzocyclohepten-Derivaten
CH492671A (de) Verfahren zur Herstellung von Dibenzocyclohepten-Derivaten
AT261293B (de) Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids

Legal Events

Date Code Title Description
PL Patent ceased